This is followed by an increasing trend in HF hospitalizations along with an enormous economic burden that also keeps growing [ 3 , 4 ].
← all excerpts
Drug therapy for patients with systolic heart failure after the PARADIGM-HF trial: in need of a new paradigm of LCZ696 implementation in clinical practice.
1
—
—